Style | Citing Format |
---|---|
MLA | Farzaneh S, et al.. "Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan." Journal of Isfahan Medical School, vol. 40, no. 685, 2022, pp. 654-658. |
APA | Farzaneh S, Norouzi F, Fazeli H, Moghim S, Esfahani BN (2022). Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan. Journal of Isfahan Medical School, 40(685), 654-658. |
Chicago | Farzaneh S, Norouzi F, Fazeli H, Moghim S, Esfahani BN. "Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan." Journal of Isfahan Medical School 40, no. 685 (2022): 654-658. |
Harvard | Farzaneh S et al. (2022) 'Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan', Journal of Isfahan Medical School, 40(685), pp. 654-658. |
Vancouver | Farzaneh S, Norouzi F, Fazeli H, Moghim S, Esfahani BN. Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan. Journal of Isfahan Medical School. 2022;40(685):654-658. |
BibTex | @article{ author = {Farzaneh S and Norouzi F and Fazeli H and Moghim S and Esfahani BN}, title = {Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan}, journal = {Journal of Isfahan Medical School}, volume = {40}, number = {685}, pages = {654-658}, year = {2022} } |
RIS | TY - JOUR AU - Farzaneh S AU - Norouzi F AU - Fazeli H AU - Moghim S AU - Esfahani BN TI - Resistance to First-Line Drugs in Clinical Isolates of Mycobacterium Tuberculosis in Isfahan JO - Journal of Isfahan Medical School VL - 40 IS - 685 SP - 654 EP - 658 PY - 2022 ER - |